ArticleBMJ open2021

Randomised controlled trial to investigate optimal antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: a study protocol of the OPTIMA-AF trial.

Yohei Sotomi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.